Loading Events

« All Events

Oligonucleotides for CNS Summit 2021

February 22 - February 24

Location: Digital Event

The 1st Oligonucleotides for CNS Summit is a ground-breaking new forum dedicated to helping you optimize ASOs, RNAi, and mRNA from target-specific delivery to the clinic and achieve full therapeutic benefit in neurodegenerative and neuromuscular disorders.

Network with over 50 other industry pioneers including Strand Therapeutics, Vect-Horus, and Enable Therapeutics to hear first-hand how the latest scientific research is innovating and upgrading oligonucleotide therapeutics at this trailblazing new meeting.

Unmissable highlights include:

  • Analyze preclinical experience with siRNAs targeting APP in the CNS with Alnylam Pharmaceuticals to examine the benefits and drawbacks of intrathecal delivery
  • Maximize your pre-clinical trials by discovering how to translate a pre-clinical success into a clinical one thanks to oligonucleotide therapeutics alongside Biogen
  • Hear how to optimize oligonucleotide therapeutic design with AstraZeneca and understand which linker molecule to choose in order to minimize toxicity and optimize potency
  • Uncover how to methodically design safe oligonucleotides with Khvorova Lab at UMASS Medical School to boost your candidates’ therapeutic benefit and minimize risk
  • Deep dive into intracranial, intrathecal, intravenous, targeted, and intranasal delivery with miCure therapeutics to determine which oligonucleotide delivery method best suits the treatment of different diseases

Join 50+ CNS heavyweights as they come together to discover, advance, and action the potential of emerging RNA therapeutics to transform their pipelines against neurodegenerative and neuromuscular disease.



February 22
February 24
Event Categories:
, , , ,